Company intelligence / Profile preview

Bioshield Pharma

Brazil
Ownership
Private
Development stage
Preclinical
01

Overview

BioShield Life Sciences aims to be Latin America's first large-scale advanced biologics CDMO. It provides end-to-end development and manufacturing services for biologics—including monoclonal antibodies, vaccines (including mRNA), cell/gene therapies—targeting both regional health needs and global partners. No clinical results are reported since it does not develop its own drugs.

Therapeutic areas
OncologyPulmonologyEndocrinologyHematologyGastroenterologyNeurologyInfectious Diseases
Modalities
Monoclonal antibodies (novel & biosimilars)Therapeutic proteins (mammalian & microbial)CAR-T cell therapyOther cell & gene therapiesStem cellsmRNA therapeuticsSelf-replicating RNAVirus-like particles (VLP)Adeno-associated virus vectors (AAV)Modified Vaccinia Ankara vectorsLentiviral vectorsBaculovirus-based products
Industry
Contract Manufacturing Organization

Beyond the preview

Go deeper on Bioshield Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bioshield Pharma.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call